Newsletter Archive

  1. 06.20.17 -- Accenture Labs, 1QBit, And Biogen Apply Quantum Computing To Drug Discovery
    6/20/2017
    06/20/17 Drug Discovery Online Newsletter
  2. 06.19.17 -- Biologic Drug Substance Manufacturing Risks: What You Can’t Afford To Ignore
    6/19/2017
    06/19/17 Drug Discovery Online Newsletter
  3. 06.14.17 -- Bring Biologics To Clinic Faster
    6/14/2017
    06/14/17 Drug Discovery Online Newsletter
  4. 06.13.17 -- Synlogic Meets First Discovery Milestone In Partnership With AbbVie
    6/13/2017
    06/13/17 Drug Discovery Online Newsletter
  5. 06.06.17 -- FDA Grants Breakthrough Therapy Designation For Alnylam’s Givosiran
    6/6/2017
    06/06/17 Drug Discovery Online Newsletter
  6. 05.30.17 -- Geneious Biologics To Power Better Biological Drug Development
    5/30/2017
    05/30/17 Drug Discovery Online Newsletter
  7. 05.23.17 -- X-Chem And Vertex Enter Into Multi-Target Genetic Disease Collaboration
    5/23/2017
    05/23/17 Drug Discovery Online Newsletter
  8. 05.19.17 -- Oral Delivery Of Challenging Molecules
    5/19/2017
    05/19/17 Drug Discovery Online Newsletter
  9. 05.16.17 -- Cell-Penetrating Antibodies To Oncogenic RAS Show Anti-Tumor Activity
    5/16/2017
    05/16/17 Drug Discovery Online Newsletter
  10. 05.09.17 -- Ensuring The Greatest Return From Your Poorly Soluble Molecule
    5/9/2017
    05/09/17 Drug Discovery Online Newsletter